SK7042000A3 - Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis - Google Patents

Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis Download PDF

Info

Publication number
SK7042000A3
SK7042000A3 SK704-2000A SK7042000A SK7042000A3 SK 7042000 A3 SK7042000 A3 SK 7042000A3 SK 7042000 A SK7042000 A SK 7042000A SK 7042000 A3 SK7042000 A3 SK 7042000A3
Authority
SK
Slovakia
Prior art keywords
methyl
dideoxy
use according
ketolides
imino
Prior art date
Application number
SK704-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Francis Petit
Francoise Vacheron
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of SK7042000A3 publication Critical patent/SK7042000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SK704-2000A 1997-11-17 1998-11-16 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis SK7042000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
SK7042000A3 true SK7042000A3 (en) 2000-12-11

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
SK704-2000A SK7042000A3 (en) 1997-11-17 1998-11-16 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis

Country Status (35)

Country Link
US (1) US20080139489A1 (es)
EP (1) EP1030673B1 (es)
JP (1) JP4550273B2 (es)
KR (1) KR20010032130A (es)
CN (1) CN1286633A (es)
AP (1) AP1196A (es)
AR (1) AR014119A1 (es)
AT (1) ATE271875T1 (es)
AU (1) AU744419B2 (es)
BG (1) BG104427A (es)
BR (1) BR9814199A (es)
CA (1) CA2312021C (es)
DE (1) DE69825308T2 (es)
DZ (1) DZ2654A1 (es)
EA (1) EA003322B1 (es)
EE (1) EE04095B1 (es)
ES (1) ES2224446T3 (es)
FR (1) FR2771008B1 (es)
GE (1) GEP20032968B (es)
HR (1) HRP20000314A2 (es)
HU (1) HUP0004507A3 (es)
ID (1) ID24940A (es)
IL (1) IL136149A0 (es)
MA (1) MA26566A1 (es)
NO (1) NO20002435L (es)
NZ (1) NZ504305A (es)
OA (1) OA11411A (es)
PL (1) PL340373A1 (es)
SK (1) SK7042000A3 (es)
TN (1) TNSN98206A1 (es)
TR (1) TR200001384T2 (es)
TW (1) TW472061B (es)
WO (1) WO1999025365A1 (es)
YU (1) YU29600A (es)
ZA (1) ZA9810357B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
WO2000034297A1 (en) * 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
ATE256694T1 (de) * 1999-01-27 2004-01-15 Pfizer Prod Inc Ketolid-antibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
CZ20023290A3 (cs) 2000-04-04 2003-03-12 Smithkline Beecham Plc 2-Hydroxymutilinkarbamátové deriváty pro antibakteriální použití
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
NO20002435D0 (no) 2000-05-11
AP1196A (en) 2003-08-18
AU1242599A (en) 1999-06-07
TW472061B (en) 2002-01-11
OA11411A (fr) 2004-04-20
NO20002435L (no) 2000-07-07
FR2771008B1 (fr) 2000-04-28
EA003322B1 (ru) 2003-04-24
MA26566A1 (fr) 2004-12-20
TNSN98206A1 (fr) 2005-03-15
DE69825308T2 (de) 2005-08-04
TR200001384T2 (tr) 2001-06-21
ID24940A (id) 2000-08-31
KR20010032130A (ko) 2001-04-16
HUP0004507A1 (hu) 2001-05-28
HUP0004507A3 (en) 2001-12-28
EE04095B1 (et) 2003-08-15
EP1030673A1 (fr) 2000-08-30
DE69825308D1 (de) 2004-09-02
EE200000244A (et) 2001-06-15
US20080139489A1 (en) 2008-06-12
ZA9810357B (en) 1999-11-12
GEP20032968B (en) 2003-05-27
IL136149A0 (en) 2001-05-20
YU29600A (sh) 2003-02-28
HRP20000314A2 (en) 2001-02-28
AU744419B2 (en) 2002-02-21
CN1286633A (zh) 2001-03-07
BR9814199A (pt) 2000-09-26
ES2224446T3 (es) 2005-03-01
NZ504305A (en) 2002-11-26
FR2771008A1 (fr) 1999-05-21
JP4550273B2 (ja) 2010-09-22
JP2001523644A (ja) 2001-11-27
PL340373A1 (en) 2001-01-29
CA2312021C (fr) 2008-08-26
DZ2654A1 (fr) 2003-03-22
WO1999025365A1 (fr) 1999-05-27
CA2312021A1 (fr) 1999-05-27
EP1030673B1 (fr) 2004-07-28
EA200000531A1 (ru) 2000-10-30
ATE271875T1 (de) 2004-08-15
AP2000001825A0 (en) 2000-06-30
AR014119A1 (es) 2001-02-07
BG104427A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
US5721219A (en) N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation
US20080139489A1 (en) Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
EP2591784B1 (en) Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system
SK19872000A3 (sk) Inhibítory farnezyl-proteín transferázy na liečbu artropatií
RU2611662C2 (ru) Способы лечения или профилактики тромбообразования или эмболии
KR20100023836A (ko) 혈소판 ａｄｐ 수용체 억제제로 작용하는 화합물을 이용한 병용요법
HU228937B1 (en) Compositions for treating inflammatory response
KR20100061666A (ko) 면역학적 및 염증성 질환 및 장애의 치료를 위한 조성물 및 방법
KR20200108330A (ko) 포스포르(포스포론)아미다타세탈 및 포스프(온)아탈세탈 화합물
CZ20001798A3 (cs) Použití ketolidů pro přípravu farmaceutických prostředků určených pro předcházení arteriálním trombotickým komplikacím spojeným s atherosklerosou
JP6695361B2 (ja) 重水素化チエノピペリジン誘導体、調製方法、及びその使用
JPS6150926B2 (es)
MXPA00004771A (es) Utilizacion de cetolidas para prevenir las complicaciones tromboticas arteriales vinculadas a la ateroesclerosis
BRPI0611096A2 (pt) (5z)-5-(6-quinoxalinilmetilideno)-2-[(2,6-diclorofenil)a mino]-1,3-tiazol-4(5h)-ona
HU201082B (en) Enolethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide, a process for their preparation and their use.
US4775681A (en) Method of treating fungal infections with trans-6-[2-substitutedpyrrol-1-yl)alkyl]-4-hydroxypyran-2-ones
EP2258364A1 (en) Preventive and/or remedy for vascular diseases
US3721738A (en) Treatment and prophylaxis of thrombovascular diseases with 2-imidazolone derivatives
WO2003053439A1 (en) Use of benzofuroxan derivatives as antiplatelet agents
AU2012216834A1 (en) Pyridone Derivatives for Modulating Stress-Activated Protein Kinase System